369 related articles for article (PubMed ID: 16860316)
1. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
2. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
Hao L; ElShamy WM
Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence.
Shiozawa T; Miyamoto T; Kashima H; Nakayama K; Nikaido T; Konishi I
Oncogene; 2004 Nov; 23(53):8603-10. PubMed ID: 15467760
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
Ouafik L; Berenguer-Daize C; Berthois Y
Cell Signal; 2009 Apr; 21(4):597-608. PubMed ID: 19166930
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
[TBL] [Abstract][Full Text] [Related]
6. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
7. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
[TBL] [Abstract][Full Text] [Related]
8. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression.
Planas-Silva MD; Donaher JL; Weinberg RA
Cancer Res; 1999 Oct; 59(19):4788-92. PubMed ID: 10519385
[TBL] [Abstract][Full Text] [Related]
9. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
[TBL] [Abstract][Full Text] [Related]
10. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
13. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
14. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
15. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.
Wittmann BM; Fujinaga K; Deng H; Ogba N; Montano MM
Oncogene; 2005 Aug; 24(36):5576-88. PubMed ID: 15940264
[TBL] [Abstract][Full Text] [Related]
16. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Lafarge S; Sylvain V; Ferrara M; Bignon YJ
Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
19. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
Xiao D; Chinnappan D; Pestell R; Albanese C; Weber HC
Cancer Res; 2005 Nov; 65(21):9934-42. PubMed ID: 16267018
[TBL] [Abstract][Full Text] [Related]
20. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
